K
Kenji Okada
Researcher at Fukuoka Dental College
Publications - 65
Citations - 1446
Kenji Okada is an academic researcher from Fukuoka Dental College. The author has contributed to research in topics: Vaccination & Diphtheria. The author has an hindex of 19, co-authored 63 publications receiving 1261 citations.
Papers
More filters
Journal ArticleDOI
Practice guidelines for therapeutic drug monitoring of voriconazole: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring.
Yukihiro Hamada,Issei Tokimatsu,Hiroshige Mikamo,Masao Kimura,Masafumi Seki,Shunji Takakura,Norio Ohmagari,Yoshiko Takahashi,Kei Kasahara,Kazuaki Matsumoto,Kenji Okada,Masahiro Igarashi,Masahiro Kobayashi,Takahiro Mochizuki,Yoshifumi Nishi,Yusuke Tanigawara,Toshimi Kimura,Yoshio Takesue +17 more
TL;DR: This guideline evaluated the scientific data associated with serum ABK monitoring and provided recommendations based on the available evidence and potential limitations include the findings that few prospective clinical trials of TDM of ABK are available in the treatment of MRSA infections and that most of the published literature describes observational studies.
Journal ArticleDOI
Palivizumab Prophylaxis in Preterm Infants and Subsequent Recurrent Wheezing. Six-Year Follow-up Study.
Hiroyuki Mochizuki,Satoshi Kusuda,Kenji Okada,Shigemi Yoshihara,Hiroyuki Furuya,Eric A. F. Simões +5 more
TL;DR: Palivizumab prophylaxis administered to preterm infants did not suppress the onset of atopic asthma but resulted in a significantly lower incidence of recurrent wheezing during the first 6 years.
Journal ArticleDOI
Effect of Palivizumab Prophylaxis on Subsequent Recurrent Wheezing in Preterm Infants
Shigemi Yoshihara,Satoshi Kusuda,Hiroyuki Mochizuki,Kenji Okada,Sankei Nishima,Eric A. F. Simões +5 more
TL;DR: Palivizumab prophylaxis administered to preterm infants 33 to 35 weeks’ gestational age is associated with a significantly lower incidence of recurrent wheezing during the first 3 years of life.
Journal ArticleDOI
Aseptic meningitis caused by measles-mumps-rubella vaccine in Japan.
Journal ArticleDOI
Nationwide population-based surveillance of invasive pneumococcal disease in Japanese children: Effects of the seven-valent pneumococcal conjugate vaccine
Shigeru Suga,Bin Chang,Kazutoyo Asada,Hideki Akeda,Junichiro Nishi,Kenji Okada,Hiroshi Wakiguchi,Akihiko Maeda,Megumi Oda,Naruhiko Ishiwada,Akihiko Saitoh,Tomohiro Oishi,Mitsuaki Hosoya,Takehiro Togashi,Kazunori Oishi,Toshiaki Ihara +15 more
TL;DR: A 98% decline in IPD incidence caused by PCV7 serotypes in children aged <5 years and serotype replacement afterPCV7 introduction in Japan is confirmed, showing the importance of continuing surveillance of serotypes responsible for IPD and their antimicrobial resistance in Japan.